ECOG performance status was found to capture only part of the patient experience in gastric/GEJ adenocarcinoma. Among patients with gastric or gastroesophageal junction (GEJ) adenocarcinoma, those ...

At its core, healthcare is a people business. When organizations listen to patients and act on what they hear, they build ...

Wearable activity monitors could be useful in assessing the health of cancer patients and making predictions about mortality and adverse events, according to a study published last week in Nature's ...

ECOG performance status is an important risk factor for early mortality in metastatic castration-resistant prostate cancer (mCRPC). Patients with metastatic castration-resistant prostate cancer (mCRPC ...

Chemoimmunotherapy extended PFS compared with chemotherapy for patients with extensive-stage small cell lung cancer and ECOG performance status of 2 or 3, according to retrospective study results. The ...

Association of symptom severity, anxiety, and health literacy with portal usage among patients with cancer. AI-enabled digital test to predict disease recurrence for patients with early-stage invasive ...

We surveyed medical oncologists involved in the care of a population-based cohort of patients with lung cancer from the CanCORS (Cancer Care Outcomes Research and Surveillance) study. Physicians were ...

Accurately diagnosing and staging patients with upper tract urothelial carcinoma (UTUC) has proven challenging for clinicians. Experts at Memorial Sloan Kettering recently applied genomic sequencing ...

Please provide your email address to receive an email when new articles are posted on . Patient-reported physical function predicts which patients gain greatest survival benefit from daratumumab.